J. Welch

发表

Dietary intake and childhood leukemia: The Diet and Acute Lymphoblastic Leukemia Treatment (DALLT) cohort study.

S. Sallan, L. Silverman, K. Kelly, 2016, Nutrition.

An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana‐Farber Cancer Institute ALL Consortium protocol 05‐001

D. Neuberg, S. Sallan, Zhezhen Jin, 2018, Pediatric blood & cancer.

Genetic ancestry and skeletal toxicities among childhood acute lymphoblastic leukemia patients in the DFCI 05-001 cohort.

Qianqian Zhu, S. Sallan, M. Harris, 2019, Blood advances.

Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana‐Farber Cancer Institute ALL Consortium trial 05‐001

Traci M. Blonquist, D. Neuberg, S. Sallan, 2022, Pediatric blood & cancer.

A Case Report of Pediatric Paraneoplastic Dysautonomia.

B. Alverson, J. Mann, J. Welch, 2018, Pediatric emergency care.

Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia

Traci M. Blonquist, D. Neuberg, S. Sallan, 2015, Pediatric blood & cancer.

Mutations within the Activation Loop Domain of FLT3 in Two Pediatric Patients with Refractory Infant Acute Myeloid Leukemia

R. MacDonell-Yilmaz, Robyn Borsuk, J. Welch, 2020, Case Reports in Oncology.

Leukemic Infiltration of the Optic Nerve.

R. Janigian, R. MacDonell-Yilmaz, P. Channa, 2019, Journal of oncology practice.

Identification of prognostic factors in childhood T‐cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05‐001 and 11‐001

D. Neuberg, S. Sallan, M. Sulis, 2020, Pediatric blood & cancer.

Direct CNS administration of rituximab and epratuzumab in a pediatric patient with relapsed refractory CNS B‐cell acute lymphoblastic leukemia

J. Welch, A. Chawla, Jenna McClane, 2022, Pediatric blood & cancer.

Two cases of humoral hypercalcemia of malignancy complicating infantile fibrosarcoma

D. Harrison, Robin Kremsdorf, J. Welch, 2017, Pediatric blood & cancer.

Management of childhood cancer survivors at risk for thyroid function abnormalities: A Delphi study

P. Nathan, L. Cohen, M. Hudson, 2022, Pediatric blood & cancer.

Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia.

M. Loh, D. Neuberg, S. Sallan, 2018, Blood advances.

Oral Mercaptopurine Adherence in Pediatric Acute Lymphoblastic Leukemia: A Survey Study From the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium

L. Silverman, K. Kelly, P. Cole, 2022, Journal of pediatric hematology/oncology nursing.

Parental needs for information related to neurocognitive late effects from pediatric cancer and its treatment

E. Jelalian, C. Schwartz, P. Manley, 2009, Pediatric blood & cancer.

Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001

Traci M. Blonquist, D. Neuberg, S. Sallan, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized Study of Pegasparagase (SS-PEG) and Calaspargase Pegol (SC-PEG) in Pediatric Patients with Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: Results of DFCI ALL Consortium Protocol 11-001

D. Neuberg, S. Sallan, M. Sulis, 2016 .

Acute Myocardial Dysfunction and Hypereosinophilic Infiltrative Myocarditis Secondary to New-Onset Pediatric Acute Lymphoblastic Leukemia

Saurabh Agarwal, R. MacDonell-Yilmaz, R. Rozenfeld, 2021, JACC. Case reports.

Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma.

D. Friedman, A. Buxton, R. Ambinder, 2017, Blood advances.

Evaluation of knowledge and comfort with opioid prescribing among pediatric hematology/oncology fellows

Anarina L. Murillo, R. MacDonell-Yilmaz, J. Welch, 2020, Pediatric blood & cancer.

Fluctuations in dietary intake during treatment for childhood leukemia: A report from the DALLT cohort.

S. Sallan, L. Silverman, K. Kelly, 2019, Clinical nutrition.

Parental Interest in a Bereavement Support Visit When a Child Dies from Cancer

E. Jelalian, E. Forman, J. Boergers, 2012, Omega.

Early Lifestyle Intervention for Obesity Prevention in Pediatric Survivors of Acute Lymphoblastic Leukemia

M. Scheurer, Z. Dreyer, Michael Kelly, 2019, Nutrients.

Severe Vincristine-related Neurotoxicity in 5 Patients With Pediatric Acute Lymphoblastic Leukemia Requiring Discontinuation of Vincristine: A Description of Long-term Outcome

M. Sulis, P. Cole, J. Kahn, 2021, Journal of pediatric hematology/oncology.

Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia

L. Silverman, V. Vijayanathan, S. Sands, 2017, Supportive Care in Cancer.

Outcome of children and adolescents with Down syndrome treated on Dana‐Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00–001 and 05‐001

D. Neuberg, S. Sallan, M. Sulis, 2018, Pediatric blood & cancer.

Feasibility of serial neurocognitive assessment using Cogstate during and after therapy for childhood leukemia

M. Sulis, L. Silverman, K. Kelly, 2023, Supportive Care in Cancer.

Feasibility of oncology clinical trial‐embedded evaluation of social determinants of health

L. Silverman, K. Kelly, J. Wolfe, 2022, Pediatric blood & cancer.

C. Trask, J. Welch, Sarah Harney, 2022, Journal of pediatric hematology/oncology.

Spontaneous expectoration of pulmonary metastases in a child with osteogenic sarcoma

S. Mangray, J. Welch, B. Denardo, 2019, Pediatric blood & cancer.

Rare Pediatric Non‐Hodgkin Lymphomas: A Report From Children's Oncology Group Study ANHL 04B1

Lynette M. Smith, S. Perkins, C. Bollard, 2016, Pediatric blood & cancer.

Higher Incidence of Treatment-Related Toxicities in Non-Hispanic Patients Undergoing Therapy for Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia on Dana-Farber Cancer Institute ALL Consortium Protocol 05-001

D. Neuberg, S. Sallan, Zhezhen Jin, 2015 .

Impairment of health-related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium.

D. Neuberg, S. Sallan, L. Silverman, 2023, Pediatric blood & cancer.

Genetic ancestry and skeletal toxicities among childhood acute lymphoblastic leukemia patients in the DFCI 05-001 cohort.

Qianqian Zhu, S. Sallan, M. Harris, 2021, Blood advances.